Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Thursday, November 05, 2020
Qualigen has signed a contract with WuXi STA for GMP production of AS1411, Qualigen's lead drug candidate for the treatment of COVID-19 and other viral diseases, for potential clinical trials.
read more
Wednesday, December 16, 2020
Qualigen Therapeutics has completed the recertification of its supply of AS1411, and has begun final formulation and filling for use in the Company's proposed Phase 2a efficacy trials of AS1411 for the treatment of patients with COVID-19.
read more
Tuesday, November 28, 2017
Quad Technologies has opened a new, larger headquarters and laboratory that allows the company to expand manufacturing capabilities for QuickGel.
read more
Wednesday, October 26, 2022
QSAM Biosciences, Inc. announced the addition of Rutgers Cancer Institute of New Jersey (RCINJ) as a clinical trial site approved to begin enrolling patients into the Phase 1 study evaluating CycloSam® in treating patients with bone cancer that ...
read more
Wednesday, February 08, 2017
Quality Packaging Specialists International has acquired 100% ownership of International Labs in an equity exchange transaction. Terms of the transaction were not disclosed. INL, based in St. Petersburg, FL, delivers adherence packaging solutions for...
read more
Monday, February 04, 2019
QPS announced a three-fold expansion of its U.S.-based Translational Medicine division, which supports nucleic acid therapeutics.
read more
Wednesday, November 16, 2022
QPS recently opened a second preclinical research facility in Taipei, Taiwan. The 2,793-square-foot facility will facilitate a research expansion into additional toxicology studies and a newly launched capability in pharmacology studies.
read more
Tuesday, November 27, 2018
QPS announced the expansion of its U.S.-based Phase I clinical trial capabilities to support the growing needs of its pharmaceutical, biotechnology and CRO partners.
read more
Wednesday, December 05, 2018
QPS, a GLP/GCP-compliant contract research organization (CRO) supporting discovery, preclinical and clinical drug development, has announced the expansion of its U.S.-based Phase I clinical trial capabilities to support the growing needs of its ...
read more
Wednesday, September 18, 2019
QPS has expanded its global footprint with new clinics in the Netherlands and India and a new bioanalytical facility in China.
read more
QPS is reinforcing its focus on qualitative and quantitative bioanalysis of biotherapeutics.
read more
QPS announced the readiness of an access restricted bioanalysis lab prepared to analyze COVID-19 clinical trial samples.
read more
QPS has announced a newly developed capability to conduct COVID-19 testing, available as of May 11, 2020.
read more
QPS continues to expand and align its full service preclinical, bioanalysis and clinical capabilities with enhanced offerings across the medical, regulatory and biotech divisions.
read more
QPharma, a leader in Medical, Commercial and Compliance Services for the life sciences industry is proud to announce the launch of Neolytica, a subsidiary, that will take healthcare analytics to an entirely new level.
read more